{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:16:51Z","timestamp":1791227811470,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ejps.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T07:06:47Z","timestamp":1274252807000},"page":"385-403","source":"Crossref","is-referenced-by-count":339,"title":["Strategy for effective brain drug delivery"],"prefix":"10.1016","volume":"40","author":[{"given":"M. Intakhab","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwar","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdus","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.cgt.7700437","article-title":"Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors","volume":"9","author":"Abe","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib2","doi-asserted-by":"crossref","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","author":"Ali","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib3","first-page":"57","article-title":"Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles","volume":"59","author":"Aliautdin","year":"1996","journal-title":"Eksp. Klin. Farmakol."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0169-409X(95)00029-7","article-title":"Pharmacokinetics of long-ciculating liposomes","volume":"16","author":"Allen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000047855","article-title":"Pericytes: Cell biology and pathology","volume":"169","author":"Allt","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.ejps.2010.05.003_bib6","first-page":"44","article-title":"Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles","volume":"41","author":"Alyautdin","year":"1995","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1012098005098","article-title":"Delivery of loperamide across the blood\u2013brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"14","author":"Alyautdin","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/02652049809006836","article-title":"Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate study","volume":"15","author":"Alyautdin","year":"1998","journal-title":"J. Microencapsul."},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib9","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","article-title":"Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience","volume":"15","author":"Attenello","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/17425240902939143","article-title":"The potential for nanopaticle based drug delivery to the brain: overcoming the blood\u2013brain barrier","volume":"6","author":"Barbu","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: the problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-3659(99)00250-3","article-title":"Development of microspheres for neurological disorders: basics to clinical applications","volume":"65","author":"Benoit","year":"2000","journal-title":"J. Control Release"},{"issue":"5","key":"10.1016\/j.ejps.2010.05.003_bib13","first-page":"600","article-title":"Physiology and pharmacological role of the blood\u2013brain barrier","volume":"60","author":"Bernacki","year":"2008","journal-title":"Pharmacol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.ejps.2010.05.003_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(00)00139-3","article-title":"Delivery of peptides and proteins through the blood\u2013brain barrier","volume":"46","author":"Bickel","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/107327480401100304","article-title":"Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor","volume":"11","author":"Black","year":"2004","journal-title":"Cancer Control."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0169-409X(98)00090-8","article-title":"Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems","volume":"36","author":"Bodor","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib17","series-title":"Peptide Based Drug Design: Controlling Transport and Metabolism","first-page":"317","author":"Bodor","year":"1995"},{"key":"10.1016\/j.ejps.2010.05.003_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(03)00043-1","article-title":"Facilitation of drug entry into the CNS via transient permeation of blood\u2013brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist","volume":"60","author":"Borlongan","year":"2003","journal-title":"Cereport. Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/j.1875-9114.1996.tb03646.x","article-title":"The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients","volume":"16","author":"Boucher","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2010.05.003_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood\u2013brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejps.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","article-title":"Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers for recurrent gliomas","volume":"345","author":"Brem","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00397918708063923","article-title":"Facile, one-step preparation of trigonellinate esters","volume":"17","author":"Brewster","year":"1987","journal-title":"Synth. Commun."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib23","first-page":"94","article-title":"The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems","volume":"57","author":"Brewster","year":"2002","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/jpet.102.039669","article-title":"Poly (ethylene glycol) coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting","volume":"303","author":"Brigger","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1474-4422(04)00944-5","article-title":"Neuro-oncology: the growing role of chemotherapy in glioma","volume":"4","author":"Carpentier","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejps.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-7799(98)01250-5","article-title":"In vivo delivery of heterologous proteins by microencapsulated recombinant cells","volume":"17","author":"Chang","year":"1999","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2010.05.003_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/jcbfm.1994.15","article-title":"The human brain GLUT-1 transporter ultra structural localization to the blood\u2013brain barrier endothelial cells","volume":"14","author":"Conford","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: Physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2003.09.004","article-title":"Sensory circumventricular organs: central roles in integrated autonomic regulation","volume":"117","author":"Cottrell","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejps.2010.05.003_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1085\/jgp.77.4.349","article-title":"Electrical resistance of capillary endothelium","volume":"77","author":"Crone","year":"1981","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejps.2010.05.003_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(82)91227-6","article-title":"Electrical resistance of brain microvascular endothelium","volume":"241","author":"Crone","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1023\/A:1007542618378","article-title":"Transfer of dopamine in the olfactory pathway following nasal administration in mice","volume":"17","author":"Dahlin","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib33","first-page":"235","article-title":"Genetic delivery of enzymes for cancer therapy","volume":"2","author":"Deonarain","year":"1995","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.ejps.2010.05.003_bib34","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/jps.21182","article-title":"Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations","volume":"97","author":"Desai","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.05.003_bib35","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.93.12.6025","article-title":"Supression substractive hybridization: A method for genetically differentially regulated or tissue-specific cDNA probes and libraries","volume":"93","author":"Diatchnenko","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.0900274","article-title":"Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS","volume":"183","author":"Dou","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2010.05.003_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0026-0495(98)90007-5","article-title":"Human blood\u2013brain barrier insulin like growth factor receptor","volume":"37","author":"Duffy","year":"1988","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1602\/neurorx.2.1.44","article-title":"Development of neuropeptide drugs that cross the blood\u2013brain barrier","volume":"2","author":"Egleton","year":"2005","journal-title":"NeuroRx"},{"issue":"9","key":"10.1016\/j.ejps.2010.05.003_bib39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0196-9781(97)00242-8","article-title":"Bioavailability and transport of peptides and peptide drugs into the brain","volume":"18","author":"Egleton","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2010.05.003_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-200140020-00003","article-title":"The development of the bradykinin agonist labradamil as a means to increase the permeability of the blood\u2013brain barrier: from concept to clinical evaluation","volume":"40","author":"Emerich","year":"2001","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","article-title":"The blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: function and dysfunction","volume":"31","author":"Engelhardt","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejps.2010.05.003_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.bjp.0705302","article-title":"Intracarotid administration of short chain alkylglycerols for increased delivery of methotrexate to the rat brain","volume":"139","author":"Erdlenbruch","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00280-002-0497-4","article-title":"Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood\u2013brain barrier using intracarotid pentylglycerol in rats","volume":"50","author":"Erdlenbruch","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ANA.0b013e3181453851","article-title":"Enhanced disruption of the blood\u2013brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits","volume":"19","author":"Etu","year":"2007","journal-title":"J. Neurosurg. Anesthesiol."},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200241060-00002","article-title":"Pharmacokinetics of the carmustine implant","volume":"41","author":"Fleming","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2010.05.003_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2337\/diabetes.30.9.757","article-title":"A direct in vitro demonstration of insulin binding to isolated brain microvessels","volume":"30","author":"Frank","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.ejps.2010.05.003_bib47","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(02)00054-6","article-title":"Local drug delivery to the brain","volume":"54","author":"Frazier","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s004010050734","article-title":"Effect of global system for mobile communication (GSM) microwave exposure on blood\u2013brain barrier permeability in rat","volume":"94","author":"Fritze","year":"1997","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.ejps.2010.05.003_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1016083113123","article-title":"Chemotherapeutic drugs released from polymers distribution of 1,3-bis (2-chloroethyl)-1-nitrosourea in the rat brain","volume":"13","author":"Fung","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(01)00311-X","article-title":"Biodegradable polymer implants to treat brain tumors","volume":"74","author":"Gabikian","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2010.05.003_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0169-409X(96)00476-0","article-title":"Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals","volume":"24","author":"Gabizon","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejps.2010.05.003_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/jm00155a018","article-title":"A lymphotropic prodrug of L-dopa: synthesis, pharmacological properties, and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)prop anoyl] propane-1,2,3-triol","volume":"29","author":"Garzon-Aburbeh","year":"1986","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31887\/DCNS.2006.8.3\/fgirardin","article-title":"Membrane transporter proteins: a challenge for CNS drug development","volume":"8","author":"Girardin","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2010.05.003_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(01)00102-3","article-title":"Molecular and cellular permeability control at the blood\u2013brain barrier","volume":"36","author":"Gloor","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jps.20318","article-title":"Nasal drug administration: Potential for targeted central nervous system delivery","volume":"94","author":"Graff","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.05.003_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(99)02089-2","article-title":"Comparison of cytosine arabinoside delivery to rat brain by i.v., intrathecal, intraventricular and intraparenchymal routes of administration","volume":"856","author":"Groothuis","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib57","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1023\/A:1018983904537","article-title":"Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles","volume":"16","author":"Gulayaev","year":"1999","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.V92.1.184.413k26_184_190","article-title":"Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapy","volume":"92","author":"Haisma","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2005.02.028","article-title":"Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice","volume":"105","author":"Harivardhan","year":"2005","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/THC-1999-7603","article-title":"Interfacing the body's own sensing receptors into neural prosthesis devices","volume":"7","author":"Haugland","year":"1999","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.ejps.2010.05.003_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The Blood\u2013brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib62","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/bja\/aeh204","article-title":"Intrathecal drug spread","volume":"93","author":"Hocking","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejps.2010.05.003_bib63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijpharm.2007.12.013","article-title":"Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity","volume":"1","author":"Huang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2005.09.053","article-title":"Barriers to carrier mediated drug and gene delivery to brain tumors","volume":"110","author":"Huynh","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2010.05.003_bib65","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.addr.2008.03.010","article-title":"Ultrasound for drug and gene delivery to the brain","volume":"60","author":"Hynynen","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.05.003_bib67","first-page":"167","article-title":"The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338)","author":"Illum","year":"1984","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.ejps.2010.05.003_bib68","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11095-005-6039-0","article-title":"Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route","volume":"22","author":"Johanson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib69","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.2004.101.6.1004","article-title":"Distribution kinetics of targeted cytotoxin in glioma by bolus or convection enhanced delivery in a murine model","volume":"101","author":"Kawakami","year":"2004","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2010.05.003_bib70","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/00001756-199806010-00007","article-title":"Restoration of neural output from a paralyzed patient by a direct brain connection","volume":"9","author":"Kennedy","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejps.2010.05.003_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1040-8428(00)00115-3","article-title":"Intrathecal chemotherapy","volume":"37","author":"Kerr","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.ejps.2010.05.003_bib72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1211\/jpp.61.05.0017","article-title":"Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats","volume":"61","author":"Khan","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2010.05.003_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2009.05.019","article-title":"Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis","volume":"213","author":"Kizelsztein","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejps.2010.05.003_bib74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(89)91079-2","article-title":"Sodium dodecyl sulphate induces a breach in the blood\u2013brain barrier and enables a West Nile virus variant to penetrate into mouse brain","volume":"496","author":"Kobiler","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2005.06.004","article-title":"Role of nanotechnology in targeted drug delivery and imaging: a concise review","volume":"1","author":"Koo","year":"2005","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2010.05.003_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib77","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/10611860802476504","article-title":"Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting","volume":"16","author":"Kumar","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2010.05.003_bib78","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/bc980123x","article-title":"Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to blood\u2013brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics and in vivo imaging of experimental brain tumors","volume":"10","author":"Kurihara","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2010.05.003_bib79","first-page":"6159","article-title":"Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood\u2013brain barrier","volume":"59","author":"Kurihara","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib80","unstructured":"Lewis, M.E., Kauer, J.C., Smith, K.R., Callison, K.V., Baldino, J.F., 1992. Treating disorders by application of insulin-like growth factor, US5093317."},{"key":"10.1016\/j.ejps.2010.05.003_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004647-200101000-00008","article-title":"Blood\u2013brain barrier genomics","volume":"21","author":"Li","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2010.05.003_bib82","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-0173(01)00083-2","article-title":"Drug delivery to damaged brain","volume":"38","author":"Lo","year":"2001","journal-title":"Brain Res. Rev."},{"issue":"9\u201310","key":"10.1016\/j.ejps.2010.05.003_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00689191","article-title":"A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo","volume":"36","author":"Longman","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood\u2013brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx."},{"key":"10.1016\/j.ejps.2010.05.003_bib86","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF01191215","article-title":"Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood\u2013brain barrier","volume":"24","author":"Lossinsky","year":"1995","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.ejps.2010.05.003_bib87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2004.12.007","article-title":"Distribution in brain liposomes after convection enhanced delivery; modulation by particle charge, particle diameter and presence of steric coating","volume":"1035","author":"MacKay","year":"2005","journal-title":"Brain Res."},{"issue":"5\u20136","key":"10.1016\/j.ejps.2010.05.003_bib88","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0684.2005.00121.x","article-title":"Simian immunodeficiency virus disrupts extended lengths of the blood\u2013brain barrier","volume":"34","author":"Maclean","year":"2005","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.ejps.2010.05.003_bib89","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/js9601602","article-title":"Controlled release of proteins to tissue transplants for treatments of neurodegenerative disorders","volume":"85","author":"Mahoney","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.05.003_bib90","first-page":"2290","article-title":"An exploratory study of ferumoxtran-10 nanoparticles as a blood\u2013brain barrier imaging agent targeting phagocytic cells in cns inflammatory lesions","volume":"26","author":"Manninger","year":"2005","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ejps.2010.05.003_bib91","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ultrasmedbio.2006.10.004","article-title":"Use of ultrasound pulses combined with definity for targeted blood\u2013brain barrier disruption: a feasibility study","volume":"33","author":"McDannold","year":"2004","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.ejps.2010.05.003_bib92","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mrm.20060","article-title":"MRI investigation of the threshold for thermally induced blood\u2013brain barrier disruption and brain tissue damage in the rabbit brain","volume":"51","author":"McDannold","year":"2007","journal-title":"Magn. Reson. Med."},{"issue":"3\u20134","key":"10.1016\/j.ejps.2010.05.003_bib93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jnci\/88.3-4.153","article-title":"Antibody-enzyme conjugates for cancer therapy","volume":"88","author":"Melton","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistrya","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib95","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/0006-2952(90)90577-8","article-title":"Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro","volume":"47","author":"Molema","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2010.05.003_bib96","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1345\/aph.19347","article-title":"Clinical pharmacology of encapsulated sustained-release cyatrabine","volume":"34","author":"Murry","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2010.05.003_bib97","first-page":"765","article-title":"Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma","volume":"6","author":"Napier","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(98)01261-2","article-title":"Extracellular space structure revealed by diffusion analysis","volume":"21","author":"Nicholson","year":"1998","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized double blind trial of glial cell line derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2010.05.003_bib101","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/cdd.1984.1.169","article-title":"Implantable devices for chronic access and drug delivery to the central nervous system","volume":"1","author":"Ommaya","year":"1984","journal-title":"Cancer Drug Deliv."},{"issue":"17","key":"10.1016\/j.ejps.2010.05.003_bib102","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.biomaterials.2008.02.020","article-title":"Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles","volume":"29","author":"Pan","year":"2008","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0972-2327.29202","article-title":"Controlled release formulations in neurology practice","volume":"9","author":"Pandit","year":"2006","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.ejps.2010.05.003_bib104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-409X(95)00007-T","article-title":"Vector mediated peptide drug delivery to the brain","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.05.003_bib105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1254\/jjp.87.97","article-title":"Brain drug targeting and gene technologies","volume":"87","author":"Pardridge","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejps.2010.05.003_bib106","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: The vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2010.05.003_bib107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Overcoming the blood\u2013brain barrier","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1602\/neurorx.2.1.1","article-title":"The blood\u2013brain barrier and neurotherapeutics","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRX"},{"issue":"1\/2","key":"10.1016\/j.ejps.2010.05.003_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2010.05.003_bib110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody under goes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood\u2013brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2009.05.004","article-title":"Transport across the blood\u2013brain barrier using albumin nanoparticles","volume":"137","author":"Park","year":"2009","journal-title":"J Control. Release"},{"key":"10.1016\/j.ejps.2010.05.003_bib112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1022592913323","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates","volume":"61","author":"Patel","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ejps.2010.05.003_bib113","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/molecules13051035","article-title":"Progress in drug delivery to the central nervous system by the prodrug approach","volume":"13","author":"Pavan","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2010.05.003_bib114","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature02072","article-title":"Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion","volume":"425","author":"Prinz","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejps.2010.05.003_bib115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P","article-title":"Targeting drugs to the brain by redox chemical delivery systems","volume":"20","author":"Prokai","year":"2000","journal-title":"Med. Res. Rev."},{"issue":"23","key":"10.1016\/j.ejps.2010.05.003_bib116","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Pruisner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpb.2008.04.018","article-title":"Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity","volume":"70","author":"Pulkkinen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib118","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(99)01479-1","article-title":"Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood\u2013brain barrier without inducing reactive gliosis","volume":"832","author":"Rabchevsky","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib119","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/10430349950019093","article-title":"Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms","volume":"10","author":"Rainov","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1007049806660","article-title":"Osmotic opening of the blood\u2013brain barrier: principles mechanism and therapeutic applications","volume":"20","author":"Rapoport","year":"2000","journal-title":"Cell Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.ejps.2010.05.003_bib121","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2174\/1381612043384916","article-title":"Drug delivery systems for brain tumor therapy","volume":"10","author":"Rautio","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib122","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v15.i6.20","article-title":"Folate-mediated targeting of therapeutic and imaging agents to cancers","volume":"15","author":"Reddy","year":"1998","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib123","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1163\/092050609X12457418779185","article-title":"Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B\/PLA-b-PEG nanoparticles","volume":"20","author":"Ren","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib124","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1096\/fasebj.9.10.7615161","article-title":"Differentiation of endothelium","volume":"9","author":"Risau","year":"1995","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rapm.2005.01.004","article-title":"Extended-duration analgesia: update on microspheres and liposomes","volume":"30","author":"Rose","year":"2005","journal-title":"Reg. Anesth. Pain. Med."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0378-5173(89)90266-4","article-title":"The effect of polysorbate 80 on brain uptake and analgesic effect of D-kyotorphin","volume":"57","author":"Sakane","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib127","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00688236","volume":"77","author":"Salahuddin","year":"1988","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib129","doi-asserted-by":"crossref","first-page":"e9532","DOI":"10.1371\/journal.pone.0009532","article-title":"Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro","volume":"5","author":"Sarafian","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2010.05.003_bib130","first-page":"211","article-title":"Pharmacology of intrathecal VP-16-213 in dogs","volume":"13","author":"Savarj","year":"1992","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2010.05.003_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2010.05.003_bib132","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1537-1891(02)00202-1","article-title":"Drug delivery to brain via the blood\u2013brain barrier","volume":"38","author":"Scherrmann","year":"2002","journal-title":"Vascul. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1602\/neurorx.2.1.99","article-title":"Drug transport to brain with targeted liposomes","volume":"2","author":"Schnyder","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejps.2010.05.003_bib134","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/js980084y","article-title":"Nanoparticle technology for delivery of drugs across the blood\u2013brain barrier","volume":"87","author":"Schronder","year":"1998","journal-title":"Int. J. Pharm. Sci."},{"issue":"5433","key":"10.1016\/j.ejps.2010.05.003_bib135","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib136","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1021\/nl801503m","article-title":"Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: delivery of membrane-impermeable molecule to modulate gene expression in vivo","volume":"8","author":"Selvi","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejps.2010.05.003_bib137","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1096\/fasebj.4.2.2404820","article-title":"Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy","volume":"4","author":"Senter","year":"1990","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib138","first-page":"611","article-title":"Advances in antibody-directed enzyme prodrug therapy","volume":"6","author":"Sharma","year":"2005","journal-title":"Curr. Opin. Investig. Drugs."},{"issue":"2","key":"10.1016\/j.ejps.2010.05.003_bib139","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/10611860600635608","article-title":"Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels","volume":"14","author":"Sheetal","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2010.05.003_bib140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1020288015457","article-title":"Local chemotherapy with cisplatin-depot for glioblastoma multiforme","volume":"60","author":"Sheleg","year":"2002","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2010.05.003_bib141","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1073\/pnas.221450098","article-title":"Brain-specific expression of an exogenous gene after i.v. administration","volume":"98","author":"Shi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib142","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10611860902718680","article-title":"The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis","volume":"17","author":"Shubar","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2010.05.003_bib143","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","article-title":"Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles","volume":"109","author":"Steiniger","year":"2004","journal-title":"Int. J. Cancer."},{"issue":"9","key":"10.1016\/j.ejps.2010.05.003_bib144","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/jcbfm.2009.71","article-title":"The role of the choroid plexus in neutrophil invasion after traumatic brain injury","volume":"29","author":"Szmydynger-Chodobska","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2010.05.003_bib145","first-page":"1766","article-title":"Imaging endogenous gene expression brain cancer in vivo with [111In]-peptide nucleic acid antisense radiopharmaceutical and brain drug targeting technology","volume":"45","author":"Suzuki","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2010.05.003_bib146","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-3659(94)90132-5","article-title":"Drug delivery to the brain utilizing blood\u2013brain barrier transport systems","volume":"29","author":"Tersaki","year":"1994","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2010.05.003_bib148","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ics.2005.02.013","article-title":"Influx transporters and drug targeting: Application of peptide and cation transporters","volume":"1277","author":"Tsuji","year":"2005","journal-title":"Int. Congr. Ser."},{"key":"10.1016\/j.ejps.2010.05.003_bib149","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/mol.61.4.729","article-title":"Transport of amino acid-related compounds mediated by L-type amino acid transporter1 (LAT1): Insights into the mechanisms of substrate recognition","volume":"61","author":"Uchino","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2010.05.003_bib150","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.addr.2003.12.006","article-title":"Therapeutic applications of lipid-coated microbubbles","volume":"56","author":"Unger","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ejps.2010.05.003_bib151","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00228-009-0714-8","article-title":"Blood\u2013brain barrier transporters and response to CNS-active drugs","volume":"65","author":"Urquhart","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib152","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nano.2009.02.005","article-title":"Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution","volume":"5","author":"Vergoni","year":"2009","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib153","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0014-5793(93)80861-N","article-title":"A new application for liposomes in cancer therapy: Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs","volume":"336","author":"Vingerhodes","year":"1993","journal-title":"FASEB Lett."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib154","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc034164r","article-title":"Nanogels for oligonucleotide delivery to the brain","volume":"15","author":"Vinogradov","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2010.05.003_bib155","series-title":"Advances in Liposomal Therapeutics","first-page":"230","author":"Vyas","year":"2001"},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib156","first-page":"8","article-title":"Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of Sumatriptan","volume":"6","author":"Vyas","year":"2006","journal-title":"AAPS PharmSciTech."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2010.05.003_bib157","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib158","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0301-5629(95)00038-S","article-title":"Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo","volume":"21","author":"Vykhodtseva","year":"1995","journal-title":"Ultrasound Med. Biol."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib159","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(02)00083-8","article-title":"Enhanced brain targeting by synthesis of 3\u2032, 5\u2032-dioctanoyl-5-fluoro-2\u2032-deoxyuridine and incorporation into solid lipid nanoparticles","volume":"54","author":"Wang","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejpb.2008.07.005","article-title":"Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting","volume":"70","author":"Wang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2010.05.003_bib161","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.2741\/2443","article-title":"Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury","volume":"12","author":"Wei","year":"2007","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib162","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11095-006-9534-z","article-title":"Direct nose-to-brain transfer of morphine after nasal administration to rats","volume":"23","author":"Westin","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib163","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2005.01.009","article-title":"Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents","volume":"24","author":"Westin","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2010.05.003_bib164","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2008.03.009","article-title":"Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles","volume":"70","author":"Wilson","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.ejps.2010.05.003_bib165","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2010.05.003_bib166","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/jcbfm.1991.90","article-title":"Basic fibroblast growth factor prevents thalamic degeneration after cortical infraction","volume":"11","author":"Yamada","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.ejps.2010.05.003_bib167","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2010.05.003_bib168","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2741\/2267","article-title":"Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia","volume":"12","author":"Ying","year":"2007","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.ejps.2010.05.003_bib169","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1208\/s12248-009-9151-y","article-title":"Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging","volume":"11","author":"Zhang","year":"2009","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ejps.2010.05.003_bib170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10611860600721051","article-title":"The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats","volume":"14","author":"Zhang","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2010.05.003_bib171","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(00)03108-5","article-title":"Conjugation of brain-derived neurotrophic factor to a blood\u2013brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of nerotrophin","volume":"889","author":"Zhang","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2010.05.003_bib172","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-0016(02)00018-7","article-title":"Global non-viral gene transfer to the primate brain following intravenous administration","volume":"7","author":"Zhang","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2010.05.003_bib173","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1016\/S0021-9258(18)53058-1","article-title":"Differential expression of Na,K-ATPase alpha and beta subunit isoforms at the blood\u2013brain barrier and the choroid plexus","volume":"268","author":"Zolkovic","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2010.05.003_bib174","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1067\/mcp.2000.106932","article-title":"Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood\u2013brain barrier disruption in patients with brain lymphoma","volume":"67","author":"Zylber-Katz","year":"2000","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T21:10:58Z","timestamp":1711487458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098710001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":174,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0928098710001818"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2010.05.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}